BE706983A - - Google Patents

Info

Publication number
BE706983A
BE706983A BE706983DA BE706983A BE 706983 A BE706983 A BE 706983A BE 706983D A BE706983D A BE 706983DA BE 706983 A BE706983 A BE 706983A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE706983A publication Critical patent/BE706983A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/20Sebacic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE706983D 1966-12-21 1967-11-23 BE706983A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5260266A GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid

Publications (1)

Publication Number Publication Date
BE706983A true BE706983A (de) 1968-05-24

Family

ID=10464554

Family Applications (1)

Application Number Title Priority Date Filing Date
BE706983D BE706983A (de) 1966-12-21 1967-11-23

Country Status (4)

Country Link
BE (1) BE706983A (de)
CH (1) CH488646A (de)
DE (1) DE1668157A1 (de)
GB (1) GB1196594A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2625429T3 (es) 2003-01-23 2017-07-19 Esperion Therapeutics Inc. Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes
EP3267989A4 (de) 2015-03-13 2018-11-07 Esperion Therapeutics, Inc. Feste dosierungskombinationen und formulierungen mit etc1002 und ezetimib sowie verfahren zur behandlung oder verringerung des risikos einer kardiovaskulären erkrankung
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
MX2021015936A (es) 2019-06-21 2022-04-26 Esperion Therapeutics Inc Metodos para preparar acido bempedoico y composiciones del mismo.

Also Published As

Publication number Publication date
GB1196594A (en) 1970-07-01
DE1668157A1 (de) 1971-09-02
CH488646A (de) 1970-04-15

Similar Documents

Publication Publication Date Title
AU5895065A (de)
AU6703465A (de)
AU6597365A (de)
BE618801A (de)
AU6852465A (de)
BE694453A (de)
BE694308A (de)
BE694204A (de)
BE694118A (de)
BE693801A (de)
BE693680A (de)
BE693386A (de)
BE693374A (de)
BE693208A (de)
BE692931A (de)
BE626310A (de)
BE692812A (de)
BE692711A (de)
BE692564A (de)
BE692535A (de)
BE692534A (de)
BE692477A (de)
BE692379A (de)
BE692140A (de)
BE689701A (de)